Federal Supply Schedule 36F79722D0073
Award Date
2/15/22
Last Date to Order
2/14/27
Federal Agency
Veterans Integrated Service Network 12
Awardee
Zealand Pharma US Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 has awarded a Federal Supply Schedule (FSS) contract to Zogenix, Inc. for Drugs, Pharmaceuticals, & Hematology Related Products (FSS-61-IB). This multiple award contract has a potential value of $250,000.00 and a period of performance from April 1, 2021 to March 31, 2026. The contract aims to procure a variety of pharmaceutical and drug products that fall under the Pharmaceuticals and...
This Federal Supply Schedule contract provides pharmaceuticals and related products to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. Awarded on August 15, 2016 to Sebela Pharmaceuticals Inc., it has a potential value of $25.57 million through its period of performance ending March 31, 2024. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule master schedule, identified as FSS-61-IB. It facilitates...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Amarin Pharma, Inc. as a multiple award against the Pharmaceuticals and Drugs schedule. The contract aims to procure drugs, pharmaceuticals, and hematology related products over a potential value of $4 million through February 2024. The contract provides access to Amarin Corporation P L C's portfolio of products through the Federal...
The Department of Veterans Affairs (VA) awarded Xeris Pharmaceuticals, Inc., a small disadvantaged business manufacturer, a multiple-award Federal Supply Schedule (FSS) contract under FSS-61-IB for Pharmaceuticals and Drugs. The $4,119,200 contract has a period of performance from July 2020 to July 2025, allowing the VA's Integrated Service Network 12 to procure a range of Xeris' drug therapies, pharmaceuticals, and hematology products to support healthcare operations for veteran patients....
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, provides Pharmaceuticals and Drugs (FSS-61-IB) to federal agencies. The prime contractor, Edenbridge Pharmaceuticals, LLC (doing business as Dexcel Pharma USA), was awarded this $9,462,110.00 multiple-award contract on November 1, 2016, with a period of performance through March 31, 2026. The contract aims to procure a wide range of...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Master Schedule. The contract has a ceiling value of $1,870,730,000.00 and was awarded to Viiv Healthcare Company, a foreign-owned, for-profit manufacturer of goods. The contract has a period of performance from August...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract was awarded to Nordic Pharma, Inc., a foreign-owned, for-profit manufacturer, by the Veterans Integrated Service Network 12 (VISN 12) on May 1, 2017. The contract has a ceiling value of $700,000.00 and a period of performance that expires on October 30, 2025. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs (VA) to Veloxis Pharmaceuticals, Inc. The contract has a ceiling value of $64,557,260.00 and a period of performance from July 1, 2022 to June 30, 2027. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. As a multiple award contract,...